These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30572924)

  • 1. Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy.
    Mastroianni A; Gaibani P; Rossini G; Vocale C; Re MC; Ravaglia G; Sambri V; Varani S
    AIDS Res Ther; 2018 Dec; 15(1):27. PubMed ID: 30572924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge.
    Patole S; Burza S; Varghese GM
    Int J Infect Dis; 2014 Aug; 25():204-6. PubMed ID: 24927662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
    Abongomera C; Diro E; de Lima Pereira A; Buyze J; Stille K; Ahmed F; van Griensven J; Ritmeijer K
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006527. PubMed ID: 29799869
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    van Griensven J; Mengesha B; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Vogt F; Adriaensen W; Diro E
    Front Cell Infect Microbiol; 2018; 8():94. PubMed ID: 29651411
    [No Abstract]   [Full Text] [Related]  

  • 5. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.
    Cota GF; de Sousa MR; de Mendonça AL; Patrocinio A; Assunção LS; de Faria SR; Rabello A
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2816. PubMed ID: 24743472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia.
    Vogt F; Mengesha B; Asmamaw H; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Adriaensen W; Melsew Y; van Griensven J; Diro E
    Am J Trop Med Hyg; 2018 Oct; 99(4):957-966. PubMed ID: 30084342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis.
    Gow NJ; Davidson RN; Ticehurst R; Burns A; Thomas MG
    PLoS Negl Trop Dis; 2015; 9(8):e0003983. PubMed ID: 26305562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
    Burza S; Mahajan R; Sinha PK; van Griensven J; Pandey K; Lima MA; Sanz MG; Sunyoto T; Kumar S; Mitra G; Kumar R; Verma N; Das P
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3053. PubMed ID: 25101665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual case of post-kala-azar dermal leishmaniasis in a patient with HIV and visceral leishmaniasis co-infection.
    Elliott T; Simpson J; Naresh KN; Lockwood D; Bailey AC
    Int J STD AIDS; 2019 Oct; 30(12):1221-1223. PubMed ID: 31558131
    [No Abstract]   [Full Text] [Related]  

  • 11. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
    Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
    Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
    Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report:
    Dujardin A; de La Blanchardière A; Dina J; Stefic K; Ravel C; Bonhomme J; Verdon R; Fournier AL
    Front Immunol; 2021; 12():669723. PubMed ID: 33968076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Intravenous Pentamidine Rescue Treatment for Active Chronic Visceral Leishmaniasis in an HIV-1 Infected Patient.
    Chechi F; Corsi P; Bartolozzi D; Gaiera G; Bartoloni A; Zammarchi L
    Am J Trop Med Hyg; 2021 Nov; 106(2):639-642. PubMed ID: 34781255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
    Medrano FJ; Hernández-Quero J; Jiménez E; Pineda JA; Rivero A; Sánchez-Quijano A; Velez ID; Viciana P; Castillo R; Reyes MJ
    AIDS; 1992 Dec; 6(12):1499-503. PubMed ID: 1362880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection.
    Faucher JF; Morquin D; Reynes J; Chirouze C; Hoen B; Le Moing V
    Parasitol Int; 2016 Oct; 65(5 Pt A):444-6. PubMed ID: 27353022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
    Diro E; Blesson S; Edwards T; Ritmeijer K; Fikre H; Admassu H; Kibret A; Ellis SJ; Bardonneau C; Zijlstra EE; Soipei P; Mutinda B; Omollo R; Kimutai R; Omwalo G; Wasunna M; Tadesse F; Alves F; Strub-Wourgaft N; Hailu A; Alexander N; Alvar J
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006988. PubMed ID: 30653490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Options for Visceral Leishmaniasis and HIV Coinfection.
    Monge-Maillo B; López-Vélez R
    AIDS Rev; 2016; 18(1):32-43. PubMed ID: 26936761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV viral load and response to antileishmanial chemotherapy in co-infected patients.
    Berhe N; Wolday D; Hailu A; Abraham Y; Ali A; Gebre-Michael T; Desjeux P; Sönnerborg A; Akuffo H; Britton S
    AIDS; 1999 Oct; 13(14):1921-5. PubMed ID: 10513651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV.
    Adriaensen W; Cuypers B; Cordero CF; Mengasha B; Blesson S; Cnops L; Kaye PM; Alves F; Diro E; van Griensven J
    EBioMedicine; 2020 May; 55():102748. PubMed ID: 32361248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.